Table 2.
MALE | ||||||
Thyroid condition | Exposed group with dose detected (G1) | Exposed group with doses = 0 (G2) | Not Exposed (G3) | |||
N | % | N | % | N | % | |
Incidentalomas | 15 | 11,3 | 8 | 10,4 | 17 | 9,3 |
Nodules (single or multiple) | 5 | 3,8 | 7 | 9,1 | 34 | 18,7 |
Thyroiditis | 6 | 4,5 | 3 | 3,9 | 6 | 3,3 |
Healthy | 107 | 80,5 | 59 | 76,6 | 125 | 68,7 |
Total | 133 | 100,0 | 77 | 100,0 | 182 | 100,0 |
FEMALE | ||||||
Thyroid condition | Exposed group with dose detected (G1) | Exposed group with doses = 0 (G2) | Not Exposed (G3) | |||
N | % | N | % | N | % | |
Incidentalomas | 3 | 9,7% | 7 | 16,7% | 26 | 13,2 |
Nodules (single or multiple) | 1 | 3,2% | 4 | 9,5% | 40 | 20,3 |
Thyroiditis | 2 | 6,5% | 3 | 7,1% | 17 | 8,6 |
Healthy | 25 | 80,6% | 28 | 66,7% | 114 | 57,9 |
Total | 31 | 100,0% | 42 | 100,0% | 197 | 100,0 |